SMTL ID : 1rr8.1

Structural Mechanisms of Camptothecin Resistance by Mutations in Human Topoisomerase I

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x TTG- TTC: 2-(1-DIMETHYLAMINOMETHYL-2-HYDROXY-8-HYDROXYMETHYL-9-OXO-9,11-DIHYDRO-INDOLIZINO[1,2-B]QUINOLIN-7-YL)-2-HYDROXY-BUTYRIC ACID(Non-covalent)

TTG-TTC.1: 13 residues within 4Å: Chain A: T.10, G.11, G.12 Chain B: C.12, A.13 Chain C: N.152, E.156, R.164, K.332, D.333, T.518, N.522, Y.523 6 PLIP interactions: 6 interactions with chain C Hydrogen bonds: C:E.156, C:T.518, C:E.156, C:T.518, C:N.522 Salt bridges: C:E.156, C:K.332, C:E.156, C:K.332 Water bridges: C:N.522, C:N.522

Links

RCSB   PDBe   PDBj   PDBsum   CATH   PLIP

Citation

Chrencik, J.E. et al., Mechanisms of camptothecin resistance by human topoisomerase I mutations. J.Mol.Biol. (2004)

Release Date

2004-07-06

Peptides

DNA topoisomerase I: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

C
C

DNA topoisomerase I